( June 24, 2025) -- June 30 — The Department of Justice and Federal Trade Commission are holding a joint virtual listening session at 2 p.m. ET on “Anticompetitive Conduct by Pharmaceutical Companies Impeding Generic or Biosimilar Competition.” For more information, go to: https://www.ftc.gov....